Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emmanuel Chartier-Kastler

Showing results (71-80 of 255) with videos related to

Pageof 26
Sort By:
Presse Medicale (Paris, France : 1983)|July 15, 2003
[Use in daily urological practice of an ultrasound device for measuring bladder volume]Morgan Roupret, Emmanuel Chartier-Kastler, Vincent Hopirtean, et al.
European Urology|October 31, 2006
Topographic anatomy of a new posterior approach to the pudendal nerve for stimulationAndré Reitz, Nicolas Gobeaux, Pierre Mozer, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|July 11, 2006
[Surgical management of chronic refractory pain after TVT treatment for stress urinary incontinence]Vincent Misrai, Emmanuel Chartier-Kastler, Florence Cour, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|November 1, 2007
[Palliative treatment of symptomatic benign prostatic hyperplasia by permanent urethral stent (Ultraflex, Boston Scientific) in high surgical risk patients]Lionel Taksin, Adrien Vidart, Pierre Mozer, et al.
European Urology|September 22, 2007
Do repeat intradetrusor botulinum toxin type a injections yield valuable results? Clinical and urodynamic results after five injections in patients with neurogenic detrusor overactivityAndré Reitz, Pierre Denys, Christophe Fermanian, et al.
Neurourology and Urodynamics|April 8, 2015
Patient-reported goal achievement following onabotulinumtoxinA treatment in patients with neurogenic detrusor overactivityEmmanuel Chartier-Kastler, Eric Rovner, Zsolt Hepp, et al.
BJU International|January 21, 2015
Forkhead box protein P3 (Foxp3) expression serves as an early chronic inflammation marker of squamous cell differentiation and aggressive pathology of urothelial carcinomas in neurological patientsVéronique Phé, Morgan Rouprêt, Olivier Cussenot, et al.
World Journal of Urology|May 3, 2021
Long-term functional outcomes of artificial urinary sphincter (AMS 800™) implantation in women aged over 75 years and suffering from stress urinary incontinence caused by intrinsic sphincter deficiencyAnne Denormandie, Emmanuel Chartier-Kastler, Rebecca Haddad, et al.
The Journal of Urology|May 18, 2011
Management of stress urinary incontinence following prostate surgery with minimally invasive adjustable continence balloon implants: functional results from a single center prospective studyMorgan Rouprêt, Vincent Misraï, Pierre-Nicolas Gosseine, et al.
Urology|August 9, 2011
Functional outcomes after management of end-stage neurological bladder dysfunction with ileal conduit in a multiple sclerosis population: a monocentric experienceGuillaume Legrand, Morgan Rouprêt, Eva Comperat, et al.
Pageof 26

Showing results (71-80 of 255) with videos related to

Sort By:
Pageof 26
Presse Medicale (Paris, France : 1983)|July 15, 2003
[Use in daily urological practice of an ultrasound device for measuring bladder volume]Morgan Roupret, Emmanuel Chartier-Kastler, Vincent Hopirtean, et al.
European Urology|October 31, 2006
Topographic anatomy of a new posterior approach to the pudendal nerve for stimulationAndré Reitz, Nicolas Gobeaux, Pierre Mozer, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|July 11, 2006
[Surgical management of chronic refractory pain after TVT treatment for stress urinary incontinence]Vincent Misrai, Emmanuel Chartier-Kastler, Florence Cour, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|November 1, 2007
[Palliative treatment of symptomatic benign prostatic hyperplasia by permanent urethral stent (Ultraflex, Boston Scientific) in high surgical risk patients]Lionel Taksin, Adrien Vidart, Pierre Mozer, et al.
European Urology|September 22, 2007
Do repeat intradetrusor botulinum toxin type a injections yield valuable results? Clinical and urodynamic results after five injections in patients with neurogenic detrusor overactivityAndré Reitz, Pierre Denys, Christophe Fermanian, et al.
Neurourology and Urodynamics|April 8, 2015
Patient-reported goal achievement following onabotulinumtoxinA treatment in patients with neurogenic detrusor overactivityEmmanuel Chartier-Kastler, Eric Rovner, Zsolt Hepp, et al.
BJU International|January 21, 2015
Forkhead box protein P3 (Foxp3) expression serves as an early chronic inflammation marker of squamous cell differentiation and aggressive pathology of urothelial carcinomas in neurological patientsVéronique Phé, Morgan Rouprêt, Olivier Cussenot, et al.
World Journal of Urology|May 3, 2021
Long-term functional outcomes of artificial urinary sphincter (AMS 800™) implantation in women aged over 75 years and suffering from stress urinary incontinence caused by intrinsic sphincter deficiencyAnne Denormandie, Emmanuel Chartier-Kastler, Rebecca Haddad, et al.
The Journal of Urology|May 18, 2011
Management of stress urinary incontinence following prostate surgery with minimally invasive adjustable continence balloon implants: functional results from a single center prospective studyMorgan Rouprêt, Vincent Misraï, Pierre-Nicolas Gosseine, et al.
Urology|August 9, 2011
Functional outcomes after management of end-stage neurological bladder dysfunction with ileal conduit in a multiple sclerosis population: a monocentric experienceGuillaume Legrand, Morgan Rouprêt, Eva Comperat, et al.
Pageof 26